GlassScriptPhysician profile
Alyssa R Bramble
NPI 1316401219
$772.62
in general payments reported to CMS, 2019-2025
13 companies · $519 in 2025
The $519 reported for 2025 was more than what 81% of Surgical providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $38.12 · 2023: $115 · 2024: $100 · 2025: $519.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $735.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $734.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avita Medical Americas, LLC | $354.87 | 2023-2025 | Recell, Cohealyx, Permeaderm |
| Medline Industries LP | $101.87 | 2022-2025 | |
| Aroa Biosurgery Incorporated | $69.51 | 2024-2025 | |
| Molnlycke Health Care US, LLC | $44.52 | 2024-2025 | Mlnlyckez-Flo Fluidized Positioner, Exufiber Ag+, Mepilex Border Ag |
| Smith+Nephew, INC. | $40.04 | 2025 | Biobrane |
| Acera Surgical, INC. | $34.78 | 2023-2024 | Restrata Wound Matrix |
| Tonix Medicines, INC. | $26.26 | 2025 | Tonmya |
| Integra Lifesciences Corporation | $20.22 | 2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Polynovo North America LLC | $19.93 | 2025 | Novosorb Btm |
| Vericel Corporation | $15.94 | 2022 | |
| Abbvie INC. | $15.29 | 2024 | |
| Kci USA, INC. | $15.15 | 2023 | V.A.C. Veraflo Cleanse Choice, Prevena |
| Access Pro Medical, LLC | $14.24 | 2025 | Matriderm |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alyssa Bramble listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.